Companion Animal Specialty Drugs Market

Companion Animal Specialty Drugs Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

Companion animals’ speciality drugs are used for treatment of various diseases and disorder in different pet animals kept as companions by human.

Factors like increased adoption of pets and growing demand for better healthcare services for them are some of the primary reasons for growth of this sector.

Companion animals are kept as pets by individuals or families and include animals such as dogs, cats, rabbits, horses, goats, rats, mice, small amphibians, reptiles, and birds.

The global market for companion animal specialty drugs will most likely expand at over 6.1% CAGR between 2023 to 2032.

The companion animal specialty drugs market size was estimated to be 12.2 billion in 2021.

Boehringer Ingelheim International GmbH, Biogenesis Bago SA, Ceva Santé Animale, Elanco Animal Health Incorporated, Merck Animal Health (Merck & Co., Inc.), Virbac S.A., Piramal Group, Zoetis, NEOGEN Corporation, Vetoquinol S.A. and others are some of the key companies involved in this sector.